Resveratrol as adjuvant of non-surgical periodontitis treatment: a systematic review and meta-analysis

Authors

  • Nathália Dantas Duarte Departamento de Diagnóstico e Cirurgia, Faculdade de Odontologia de Araçatuba, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araçatuba, SP, Brazil. https://orcid.org/0000-0002-5207-6360
  • Cleber Davi Del Rei Daltro Rosa Departamento de Materiais Odontológicos e Prótese, Faculdade de Odontologia de Araçatuba, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araçatuba, SP, Brazil. https://orcid.org/0000-0002-7350-2525
  • Victor Augusto Alves Bento Departamento de Prótese, Faculdade de Odontologia de Campo Grande, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil. https://orcid.org/0000-0003-0558-4239
  • Gabriel Mulinari-Santos Departamento de Ciências Básicas, Faculdade de Odontologia de Araçatuba, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araçatuba, SP, Brazil. https://orcid.org/0000-0003-4489-6868
  • Roberta Okamoto Departamento de Ciências Básicas, Faculdade de Odontologia de Araçatuba, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araçatuba, SP, Brazil. https://orcid.org/0000-0002-6773-6966
  • Eduardo Piza Pellizzer Departamento de Materiais Odontológicos e Prótese, Faculdade de Odontologia de Araçatuba, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Araçatuba, SP, Brazil. https://orcid.org/0000-0003-0670-5004

DOI:

https://doi.org/10.4322/bds.2025.e4582

Abstract

Objective: This systematic review aims to raise evidence on the effectiveness of the use of resveratrol supplementation (RV) as an adjuvant therapy for scaling and root planning in the treatment of periodontitis. Material and Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta- Analysis Guidelines (PRISMA) and was registered in the International Database of Systematic Reviews (PROSPERO CRD42024507782). PubMed/MEDLINE, Scopus, Embase, and Cochrane Library were searched through October 2024. The PICO question was: “Is the resveratrol supplementation effective as an adjuvant therapy of non-surgical periodontitis disease treatment?”. The established inclusion criteria were: 1) randomized controlled clinical trials (RCTs), 2) a minimum of 15 patients with periodontitis disease, and 3) follow-up of at least 4 weeks. The minimum follow-up duration was 4 weeks. Results: After searching the identified databases, 166 were screened and 3 were selected for full reading. Therefore, 3 studies were included in the final analysis. The total number of participants included in the control group (placebo) was 82, while in the intervention group (RV) was 160, with a mean age of 38 years. Conclusion: Despite the limitations of the number of studies included in this systematic review, resveratrol supplementation as an adjuvant to non-surgical periodontal therapy could contribute to optimizing the treatment of periodontitis.

KEYWORDS

Periodontal diseases; Periodontitis; Phytoestrogens; Resveratrol; Systematic review.

Downloads

Download data is not yet available.

Downloads

Published

2025-04-24

How to Cite

1.
Duarte ND, Rosa CDDRD, Bento VAA, Mulinari-Santos G, Okamoto R, Piza Pellizzer E. Resveratrol as adjuvant of non-surgical periodontitis treatment: a systematic review and meta-analysis. BDS [Internet]. 2025 Apr. 24 [cited 2025 Aug. 21];28(1). Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/4582

Issue

Vol. 28 No. 1 (2025): Jan - Mar / 2025 - Published Jan 2025

Section

Systematic Review

License

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.